475.16
-1.57 (-0.33%)
| Penutupan Terdahulu | 476.73 |
| Jumlah Dagangan | 9,096 |
| Harga / Pendapatan (P/E Ke hadapan) | 27.29 |
| Harga / Jualan (P/S) | 6.89 |
| Harga / Buku (P/B) | 2.94 |
| Julat 52 Minggu |
| Margin Keuntungan | 22.02% |
| Margin Operasi (TTM) | 22.93% |
| EPS Cair (TTM) | 11.01 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 3.90% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 18.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 78.58% |
| Nisbah Semasa (MRQ) | 1.81 |
| Aliran Tunai Operasi (OCF TTM) | 758.81 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 588.83 M |
| Pulangan Atas Aset (ROA TTM) | 11.61% |
| Pulangan Atas Ekuiti (ROE TTM) | 40.82% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Waters Corporation | Bercampur | Menaik |
AISkor Stockmoo
| Nilai 35% | 2.7 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | 2.7 |
| Masa 35% | 3.0 |
| AI Technical info | NA |
| Osilator Teknikal info | 4.0 |
| Purata Bergerak Teknikal info | 1.5 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | NA |
| Persekitaran | ×0.95 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | +37.0% |
| Persetujuan Tonggak | ×1.25 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | -3.0 |
| Skor Akhir | 2.36 |
|
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 0.16% |
| % Dimiliki oleh Institusi | 98.23% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Fundsmith Llp | 30 Jun 2026 | 2,273,632 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |